ADVB News
Archived Headlines
- US IPO Weekly Recap: May IPO market ends with a quiet week 06/02/23
- Renaissance Capital's May IPO Market Update 06/01/23
- US IPO Weekly Recap: Cummins spin-off and Canadian automation company raise a combined $521 million 05/26/23
- Taiwanese diagnostics developer Advanced Biomed files for a $150 million US IPO 05/22/23
US IPO Weekly Recap: Medtech Kestra trades up as AI play CoreWeave files for a billion-dollar IPO
A sizable medical device company and a handful of small issuers went public in the first week of March, though a billion-dollar IPO filing dominated headlines.Medical device firm Kestra Medical Technologies (KMTS) upsized and priced above the range to raise...read more
Taiwanese diagnostics developer Advanced Biomed prices downsized US IPO at the $4 low end
Advanced Biomed, a Taiwanese developer of microfluidic testing equipment for early cancer screening, raised $7 million by offering 1.6 million shares at $4, the low end of the range of $4 to $6. The company offered 0.24 million fewer shares than anticipated....read more
Taiwanese diagnostics developer Advanced Biomed slashes deal size by 92% ahead of $9 million US IPO
Advanced Biomed, a Taiwanese developer of microfluidic testing equipment for early cancer screening, lowered the proposed deal size for its upcoming IPO on Monday. In its latest filing, the company also replaced sole bookrunner Univest Securities with Craft...read more
Taiwanese diagnostics developer Advanced Biomed sets terms for $113 million US IPO
Advanced Biomed, a Taiwanese developer of microfluidic testing equipment for early cancer screening, announced terms for its IPO on Wednesday.The Tainan, Taiwan-based company plans to raise $113 million by offering 25 million shares at a price range of $4 to $5....read more